in vitro Hemocompatibility testing
As part of the medical device testing panel hemocompatibility testing is essential for evaluating the safety of blood-contacting biomaterials before clinical application.
The in vitro blood exposure models are performed in accordance with the guideline ISO 10993-11, 10993-42 and 10993-123 at Eurofins Munich. For hemocompatibility assessment of a medical device, hemolysis as well as in vitro thrombosis can be tested. The later one can be subcategorized into 4 different categories: coagulation, platelet activation, haematology, and complement activation. Furthermore, Eurofins Munich is also offering testing according to ASTM regulations for the American Market (ASTM F28887, ASTM F 23828 or ASTM F 7569), ISO 1135-45 and -56 testing for transfusion equipment (chapter 7.4 – 7.7 and 8.4 – 8.7) and blood bag testing according to ISO 38264.
The following hemocompatibility tests can be performed to evaluate interactions of medical devices with blood:
Workflow of Hemocompatibility testing
Important parameters needed for sample preparation and extraction
- Type of contact: direct or indirect blood contact
- Parts of the test material to be extracted
- Temperature and exposure time
- Surface, weight or filling volume of the test material
- Number of blood donors used for testing (Europe: at least one donor, USA/Japan: at least two donors; FDA recommends three donors)
- Use of a predicate sample for a more precise data interpretation
References
- ISO 10993-1: “Evaluation and testing within a risk management process”
- ISO 10993-4: 2017 “Selection of tests for interactions with blood”
- ISO 10993-12: 2012 “Sample preparation and reference materials”
- ISO 3826-1: 2003 “Conventional containers”
- ISO 1135-4: 2015 “Transfusion sets for single use, gravity feed”
- ISO 1135-5: 2015 “Transfusion sets for single use with pressure infusion apparatus”
- ASTM F2888: “Standard Practice for Platelet Leukocyte Count—An In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials”
- ASTM F 2382: “Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT)”
- ASTM F 756: “Standard Practice for Assessment of Hemolytic Properties of Materials”